
Am J Psychiatry 1976; 133:197-202
Copyright © 1976 by American Psychiatric Association
The dopamine hypothesis of schizophrenia: focus on the dopamine receptor
SH Snyder
Alleviation of schizophrenic symptoms by phenothiazines and butyrophenones
is associated with blockade of dopamine receptors, while exacerbation of
symptoms by amphetamines appears to result from enhanced synaptic activity
of dopamine and/or norepinephrine. The author suggests that biochemical
labeling of the dopamine receptor with 3H-dopamine and 3H-haloperidol may
clarify mechanisms of drug effects on the dopamine receptor.
This article has been cited by other articles:

|
 |

|
 |
 
F. Errico, S. Rossi, F. Napolitano, V. Catuogno, E. Topo, G. Fisone, A. D'Aniello, D. Centonze, and A. Usiello
D-Aspartate Prevents Corticostriatal Long-Term Depression and Attenuates Schizophrenia-Like Symptoms Induced by Amphetamine and MK-801
J. Neurosci.,
October 8, 2008;
28(41):
10404 - 10414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Gardell, K. E. Vanover, L. Pounds, R. W. Johnson, R. Barido, G. T. Anderson, I. Veinbergs, A. Dyssegaard, P. Brunmark, A. Tabatabaei, et al.
ACP-103, a 5-Hydroxytryptamine 2A Receptor Inverse Agonist, Improves the Antipsychotic Efficacy and Side-Effect Profile of Haloperidol and Risperidone in Experimental Models
J. Pharmacol. Exp. Ther.,
August 1, 2007;
322(2):
862 - 870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Laviolette
Dopamine Modulation of Emotional Processing in Cortical and Subcortical Neural Circuits: Evidence for a Final Common Pathway in Schizophrenia?
Schizophr Bull,
July 1, 2007;
33(4):
971 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Meyer, B. K. Yee, and J. Feldon
The Neurodevelopmental Impact of Prenatal Infections at Different Times of Pregnancy: The Earlier the Worse?
Neuroscientist,
June 1, 2007;
13(3):
241 - 256.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Beaulieu, E. Tirotta, T. D. Sotnikova, B. Masri, A. Salahpour, R. R. Gainetdinov, E. Borrelli, and M. G. Caron
Regulation of Akt Signaling by D2 and D3 Dopamine Receptors In Vivo
J. Neurosci.,
January 24, 2007;
27(4):
881 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Vanover, D. M. Weiner, M. Makhay, I. Veinbergs, L. R. Gardell, J. Lameh, A. L. Del Tredici, F. Piu, H. H. Schiffer, T. R. Ott, et al.
Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2R,3R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist
J. Pharmacol. Exp. Ther.,
May 1, 2006;
317(2):
910 - 918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Vanover, S. C. Harvey, T. Son, S. R. Bradley, H. Kold, M. Makhay, I. Veinbergs, T. A. Spalding, D. M. Weiner, C. M. Andersson, et al.
Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist
J. Pharmacol. Exp. Ther.,
September 1, 2004;
310(3):
943 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Sanders and P. V. Gejman
Influential Ideas and Experimental Progress in Schizophrenia Genetics Research
JAMA,
June 13, 2001;
285(22):
2831 - 2833.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cravchik and D. Goldman
Neurochemical Individuality: Genetic Diversity Among Human Dopamine and Serotonin Receptors and Transporters
Arch Gen Psychiatry,
December 1, 2000;
57(12):
1105 - 1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Lidow and P. S. Goldman-Rakic
Differential Regulation of D2 and D4 Dopamine Receptor mRNAs in the Primate Cerebral Cortex vs. Neostriatum: Effects of Chronic Treatment with Typical and Atypical Antipsychotic Drugs
J. Pharmacol. Exp. Ther.,
November 1, 1997;
283(2):
939 - 946.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Stirling
Progress in research into the neurobiological bases of schizophrenia: A review and commentary
Journal of Research in Nursing,
January 1, 1997;
2(6):
434 - 440.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Johnson, V Seutin, and R. North
Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump
Science,
October 23, 1992;
258(5082):
665 - 667.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Andreasen
Brain imaging: applications in psychiatry
Science,
March 18, 1988;
239(4846):
1381 - 1388.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D Pickar, R Labarca, M Linnoila, A Roy, D Hommer, D Everett, and S. Paul
Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients
Science,
August 31, 1984;
225(4665):
954 - 957.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. White and R. Wang
Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons
Science,
September 9, 1983;
221(4615):
1054 - 1057.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D Lozovsky, C. Saller, and I. Kopin
Dopamine receptor binding is increased in diabetic rats
Science,
November 27, 1981;
214(4524):
1031 - 1033.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mann, M Stanley, S Gershon, and M Rossor
Mental symptoms in Huntington's disease and a possible primary aminergic neuron lesion
Science,
December 19, 1980;
210(4476):
1369 - 1371.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Potkin, F Karoum, L. Chuang, H. Cannon-Spoor, I Phillips, and R. Wyatt
Phenylethylamine in paranoid chronic schizophrenia
Science,
October 26, 1979;
206(4417):
470 - 471.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bacopoulos, E. Spokes, E. Bird, and R. Roth
Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment
Science,
September 28, 1979;
205(4413):
1405 - 1407.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Barchas, H Akil, G. Elliott, R. Holman, and S. Watson
Behavioral neurochemistry: neuroregulators and behavioral states
Science,
May 26, 1978;
200(4344):
964 - 973.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Berger
Medical treatment of mental illness
Science,
May 26, 1978;
200(4344):
974 - 981.
[Abstract]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1976
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|